Recent Study: Central America Pharmaceuticals & Healthcare Report Q3 2013
Commercial incentives for foreign drugmakers to expand in the Central American pharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending and market growth. However, the heavy reliance on imported medicine in the region provides revenuegenerating opportunities for generic drugmakers from neighbouring Latin American countries and India. We believe that Costa Rica will continue to attract investment as a regional pharmaceutical production hub. We also highlight that Panama can be a premier country in the region for...
View full press release